Genfit is a biopharmaceutical company based in France that develops treatments for liver and metabolic diseases. Its work centres on drug candidates that act on nuclear receptors, with a focus on conditions such as primary biliary cholangitis and other chronic liver disorders. The company also develops diagnostic tools related to liver health. Its customers and partners are mainly healthcare professionals, hospitals and pharmaceutical collaborators involved in clinical development and patient care.
Genfit S.A. trades under the code 0QT6 on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2233 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
62/100
Mixed trend against its averages.
See the numbers →
Above 200-day average6.4%
From 52-week high-29.0%
MomentumFair
65/100
Typical recent returns for this exchange.
See the numbers →
3-month return-23.6%
6-month return27.8%
12-month, skipping last month139.6%
Stability (higher is calmer)Weak
20/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)64.6%
Worst drawdown, 1 year (smaller is calmer)-46.6%
LiquidityWeak
39/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.25M EUR
Zero-volume days3.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 3.40 – 15.46Daily closes, split-adjusted
Signals
50-day average11.10
200-day average9.82
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.67
Technical summary
Daily
Neutral
8 bullish · 1 neutral · 7 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
8.78
Bullish
EMA 10
9.05
Bullish
SMA 20
8.85
Bullish
EMA 20
9.21
Bullish
SMA 50
11.10
Bearish
EMA 50
10.32
Bullish
SMA 100
11.66
Bearish
EMA 100
10.63
Bearish
SMA 200
9.82
Bullish
EMA 200
9.66
Bullish
Oscillators (daily)
RSI (14)
58.46
Neutral
MACD (12, 26)
-0.44
Bearish
Momentum (12)
25.86
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
218.6
Bearish
Pivot points (classic, last session)
S3
10.44
S2
10.44
S1
10.44
Pivot
10.44
R1
10.44
R2
10.44
R3
10.44
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
